Literature DB >> 22529164

Synthesis and fragmentation of hyaluronan in renal ischaemia.

Anne-Emilie Declèves1, Nathalie Caron, Virginie Voisin, Alexandre Legrand, Nadine Bouby, Anne Kultti, Markku I Tammi, Bruno Flamion.   

Abstract

BACKGROUND: The turnover of hyaluronan (HA), especially the production of low-molecular-weight fragments of HA, was examined in a model of unilateral renal ischaemia-reperfusion (IR) in rats.
METHODS: HA was extracted from the outer and inner stripe of the outer medulla (OSOM and ISOM) at different times following IR. Its fragmentation was measured using membrane filtration and size-exclusion chromatography. Quantitative reverse transcription-polymerase chain reaction, zymography and immunohistochemistry were used to assess the expression and localization of various forms of HA synthase (HAS) and hyaluronidase (HYAL). Macrophage infiltration was evaluated using immunohistochemistry.
RESULTS: HA accumulated at Day 1 mostly as high-molecular-weight (HMW) species with an elution profile similar to a reference 2500 kDa HA and at Day 14 mostly as medium- to low-size fragments. Within 1 day, HAS1 messenger RNA was up-regulated > 50- and 35-fold in OSOM and ISOM, respectively. Thereafter, HAS1 tended to normalize, while HAS2 increased steadily. Both synthetic enzymes were localized around tubules and in the interstitium. Conversely, HYAL1, HYAL2 and global hyaluronidase activity were repressed during the first 24 h. The patterns were identical in the OSOM and ISOM despite markedly different amounts of HA at baseline. There was no obvious correlation between HA deposits and macrophage infiltration.
CONCLUSIONS: In the post-ischaemic kidney, HA starts to accumulate at Day 1 mostly as HMW species. Later on, a large proportion becomes degraded into smaller fragments. This pattern is explained by coordinated changes in the expression of HA synthases and hyaluronidases, especially an early induction of HAS1. The current data open the door to timed pharmacological interventions blocking the production of HA fragments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22529164     DOI: 10.1093/ndt/gfs098

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  19 in total

Review 1.  An update on the role of the inflammasomes in the pathogenesis of kidney diseases.

Authors:  Murthy N Darisipudi; Felix Knauf
Journal:  Pediatr Nephrol       Date:  2015-07-16       Impact factor: 3.714

2.  Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and Acute Respiratory Distress Syndrome.

Authors:  Eric P Schmidt; Katherine H Overdier; Xiaojun Sun; Lei Lin; Xinyue Liu; Yimu Yang; Lee Anne Ammons; Terra D Hiller; Matt A Suflita; Yanlei Yu; Yin Chen; Fuming Zhang; Clay Cothren Burlew; Charles L Edelstein; Ivor S Douglas; Robert J Linhardt
Journal:  Am J Respir Crit Care Med       Date:  2016-08-15       Impact factor: 21.405

Review 3.  Glycocalyx in Endotoxemia and Sepsis.

Authors:  Michael S Goligorsky; Dong Sun
Journal:  Am J Pathol       Date:  2020-02-06       Impact factor: 4.307

4.  Fluorescence resonance energy transfer (FRET) and proximity ligation assays reveal functionally relevant homo- and heteromeric complexes among hyaluronan synthases HAS1, HAS2, and HAS3.

Authors:  Geneviève Bart; Nuria Ortega Vico; Antti Hassinen; Francois M Pujol; Ashik Jawahar Deen; Aino Ruusala; Raija H Tammi; Anthony Squire; Paraskevi Heldin; Sakari Kellokumpu; Markku I Tammi
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

5.  Lack of hyaluronidases exacerbates renal post-ischemic injury, inflammation, and fibrosis.

Authors:  Vanessa Colombaro; Inès Jadot; Anne-Emilie Declèves; Virginie Voisin; Laetitia Giordano; Isabelle Habsch; Jérémy Malaisse; Bruno Flamion; Nathalie Caron
Journal:  Kidney Int       Date:  2015-02-25       Impact factor: 10.612

6.  Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy.

Authors:  Thomas A VanderJagt; Monica H Neugebauer; Marilee Morgan; Donald W Bowden; Vallabh O Shah
Journal:  World J Diabetes       Date:  2015-08-10

Review 7.  Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition.

Authors:  Thomas Baudoux; Inès Jadot; Anne-Emilie Declèves; Marie-Hélène Antoine; Jean-Marie Colet; Olivia Botton; Eric De Prez; Agnieszka Pozdzik; Cécile Husson; Nathalie Caron; Joëlle L Nortier
Journal:  Front Med (Lausanne)       Date:  2022-05-04

8.  High-molecular weight hyaluronan attenuates tubulointerstitial scarring in kidney injury.

Authors:  Xinyi Wang; Swathi Balaji; Emily H Steen; Alexander J Blum; Hui Li; Christina K Chan; Scott R Manson; Thomas C Lu; Meredith M Rae; Paul F Austin; Thomas N Wight; Paul L Bollyky; Jizhong Cheng; Sundeep G Keswani
Journal:  JCI Insight       Date:  2020-06-18

9.  Hyaluronan Synthase 3 Null Mice Exhibit Decreased Intestinal Inflammation and Tissue Damage in the DSS-Induced Colitis Model.

Authors:  Sean P Kessler; Dana R Obery; Carol de la Motte
Journal:  Int J Cell Biol       Date:  2015-09-10

10.  A hyaluronan synthesis inhibitor delays the progression of diabetic kidney disease in a mouse experimental model.

Authors:  Guillermo Selman; Laisel Martinez; Andrea Lightle; Alejandra Aguilar; Daniel Woltmann; Yuxuan Xiao; Roberto I Vazquez-Padron; Loay H Salman
Journal:  Kidney360       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.